RECRUITING

Periprosthetic Fracture Registry (PPFx)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This registry supports international data collection and research on PPFx treatments after hip and knee arthroplasty. A registry such as this ultimately aims to provide far-reaching benefits to society including reduced morbidity and mortality, improved patient safety, improved quality of care and medical decision-making, reduced medical spending, and advances in orthopaedic science.

Official Title

Multicenter Prospective Registry for Periprosthetic Fractures After Hip or Knee Arthroplasty

Quick Facts

Study Start:2018-12-31
Study Completion:2027-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03378557

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age ≥18 years
  2. * Post-operative PPFx after total or hemi hip or total or unicondylar knee arthroplasty (including the acetabulum, femur, patella and proximal tibia) requiring
  3. * osteosynthesis alone or
  4. * component revision plus plate/nail osteosynthesis
  5. * Informed consent obtained, i.e.:
  6. * Ability of the patient or assigned representative to understand the content of the patient information / Informed Consent Form
  7. * Signed and dated EC / IRB approved written informed consent
  8. * Ability to attend post-operative follow up visits
  1. * Pregnancy or women planning to conceive within the study period
  2. * Prisoner

Contacts and Locations

Study Contact

Cynthia Sob
CONTACT
+41 79 893 74 28
cynthia.sob@aofoundation.org
Viola Grünenfelder
CONTACT
+41 796963397
Viola.Gruenenfelder@aofoundation.org

Principal Investigator

Karl Stoffel, MD
PRINCIPAL_INVESTIGATOR
Universitätsspital Basel

Study Locations (Sites)

University of Missouri Health Care
Columbia, Missouri, 65201
United States
Jersey City Medical Center RWJ Barnabas Health
Jersey City, New Jersey, 07302
United States
Saint Barnabas Medical Center Livingston
Livingston, New Jersey, 07039
United States
Vanderbilt University Medical Center
Nashville, Tennessee, 37232
United States

Collaborators and Investigators

Sponsor: AO Innovation Translation Center

  • Karl Stoffel, MD, PRINCIPAL_INVESTIGATOR, Universitätsspital Basel

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-12-31
Study Completion Date2027-03-31

Study Record Updates

Study Start Date2018-12-31
Study Completion Date2027-03-31

Terms related to this study

Additional Relevant MeSH Terms

  • Periprosthetic Fractures
  • Periprosthetic Fracture Around Prosthetic Joint Implant